Pathstone Holdings
MD icon

Pathstone Holdings’s Pediatrix Medical MD Stock Holding History

Pathstone Holdings’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
27,039
-2,505
-8% -$57K ﹤0.01% 1706
2026
Q1 		$632K Sell
29,544
-14,278
-33% -$297K ﹤0.01% 1636
2025
Q4 		$937K Sell
43,822
-9,116
-17% -$187K ﹤0.01% 1445
2025
Q3 		$887K Sell
52,938
-8,857
-14% -$133K ﹤0.01% 1492
2025
Q2 		$887K Sell
61,795
-17,361
-22% -$238K ﹤0.01% 1453
2025
Q1 		$1.15M Buy
79,156
+10,481
+15% +$149K 0.01% 1305
2024
Q4 		$901K Buy
68,675
+3,276
+5% +$45.2K ﹤0.01% 1418
2024
Q3 		$758K Buy
65,399
+28,170
+76% +$266K ﹤0.01% 1512
2024
Q2 		$281K Sell
37,229
-5,829
-14% -$48.2K ﹤0.01% 1972
2024
Q1 		$432K Buy
43,058
+30,392
+240% +$283K ﹤0.01% 1747
2023
Q4 		$118K Buy
+12,666
New +$131K ﹤0.01% 2131

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Pathstone Holdings's MD Position: Q2 2026 in Review

Pathstone Holdings reduced its Pediatrix Medical (MD) stake by 8.5% in Q2 2026, selling an estimated $57K and leaving 27,039 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Pathstone Holdings first reported a position in MD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.15M in Q1 2025. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Pathstone Holdings held 27,039 shares of Pediatrix Medical worth $685K as of Q2 2026.
  • Pathstone Holdings sold 2,505 Pediatrix Medical shares in Q2 2026, an estimated $57K.
  • Pediatrix Medical made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1706 holding.
  • Pathstone Holdings first reported a position in Pediatrix Medical in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Pediatrix Medical position peaked at $1.15M in Q1 2025.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.